JP2016516670A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516670A5 JP2016516670A5 JP2015559311A JP2015559311A JP2016516670A5 JP 2016516670 A5 JP2016516670 A5 JP 2016516670A5 JP 2015559311 A JP2015559311 A JP 2015559311A JP 2015559311 A JP2015559311 A JP 2015559311A JP 2016516670 A5 JP2016516670 A5 JP 2016516670A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkali metal
- base
- copper catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361770031P | 2013-02-27 | 2013-02-27 | |
| US61/770,031 | 2013-02-27 | ||
| PCT/US2014/019039 WO2014134313A1 (en) | 2013-02-27 | 2014-02-27 | Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516670A JP2016516670A (ja) | 2016-06-09 |
| JP2016516670A5 true JP2016516670A5 (enExample) | 2017-03-23 |
| JP6433922B2 JP6433922B2 (ja) | 2018-12-05 |
Family
ID=50288305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015559311A Active JP6433922B2 (ja) | 2013-02-27 | 2014-02-27 | インダゾール誘導体の調製に使用するための中間体およびその調製方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9790206B2 (enExample) |
| EP (1) | EP2961744B1 (enExample) |
| JP (1) | JP6433922B2 (enExample) |
| CN (1) | CN105073739B (enExample) |
| WO (1) | WO2014134313A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| WO2019071144A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05009459A (es) | 2003-03-03 | 2006-05-17 | Array Biopharma Inc | Inhibidores de p38 y sus metodos de uso. |
| AU2007210073B2 (en) * | 2006-01-31 | 2011-10-06 | Array Biopharma Inc. | Kinase inhibitors and methods of use thereof |
| CA2647949A1 (en) * | 2006-03-29 | 2007-11-08 | Array Biopharma Inc. | P38 inhibitors and methods of use thereof |
| TWI365185B (en) * | 2008-07-24 | 2012-06-01 | Lilly Co Eli | Amidophenoxyindazoles useful as inhibitors of c-met |
| JP5663572B2 (ja) * | 2009-07-14 | 2015-02-04 | アルバニー モレキュラー リサーチ， インコーポレイテッド | ５−ｈｔ３受容体モジュレーター、その作製方法、およびその使用 |
-
2014
- 2014-02-27 WO PCT/US2014/019039 patent/WO2014134313A1/en not_active Ceased
- 2014-02-27 US US14/770,035 patent/US9790206B2/en active Active
- 2014-02-27 JP JP2015559311A patent/JP6433922B2/ja active Active
- 2014-02-27 CN CN201480009452.4A patent/CN105073739B/zh active Active
- 2014-02-27 EP EP14710725.4A patent/EP2961744B1/en active Active